staceywhite, Author at European Medical Journal - Page 19 of 195

Novel Pharmacology Curriculum in Hematology-Oncology Fellowship Program

Thorough understanding of cancer therapeutics is a critical component of hematology–oncology (HO) training, with pharmacology…

Fertility Outcomes After Immunotherapy in Young Adults

Immune checkpoint inhibitors (ICI) are used to treat multiple types of cancer. However, there are limited studies on the long-term…

Survival Disparities in Epithelial Ovarian Cancer

Ovarian cancer represents a leading cancer-related cause of death among women in the USA, with approximately 20,890 new cases expected to…

Navigators and Racial Literacy in Cervical Cancer Care

Cervical cancer is the third most prevalent cancer in Brazilian women. Around 17,000 new cases are expected for Brazil’s 2023–2025…

EULAR 2025 Interview: Rikke Helene Moe

Rikke Helene Moe – EULAR VP HPR, Senior Researcher at Health Services Research and Innovation Unit (EHI); Center for treatment of…

Post-sepsis Viral Infection Risk in Patients with COPD

Patients with COPD who survive sepsis remain immunocompromised and are at increased risk of subsequent viral infections, including…

Effectiveness of Bronchoscopic Lung Volume Reduction in COPD

Bronchoscopic lung volume reduction (BLVR) with endobronchial valves has established effectiveness in improving lung function in patients…

Invasive Pulmonary Aspergillosis in Lung Transplant Recipients

Invasive pulmonary aspergillosis is a potentially life-threatening complication in immunocompromised patients, particularly solid organ…

Impact of Inhaled Tobramycin on Healthcare Utilization and Morbidity

Pediatric patients who are tracheostomy dependent face an increased risk of respiratory infections due to bacterial colonization by…

Psychosocial and Social Factors in Lung Transplant Survival

Long-term survival after lung transplantation remains challenging, with limited research on risk and protective factors. The role of…